Dr. Gustavo Carneiro obtained his B.Sc. from Universidade Federal do Rio de Janeiro, Brazil in 1996,
his M.Sc. from Instituto Militar de Engenharia, Brazil in 1999, and his Ph.D.
from the University of Toronto, Canada in 2004. In 2005, he was a post-doctoral
fellow at the University of British Columbia and the University of California
San Diego. From 2006 to 2008, he was a research scientist at Siemens Corporate
Research in Princeton, USA. From 2008 to 2011, he was a Marie Curie IIF fellow
and a visiting assistant professor at the Instituto Superior Tecnico (Lisbon,
Portugal) within the Carnegie Mellon University-Portugal program
(CMU-Portugal). Dr. Carneiro joined the University of Adelaide as a Senior
Lecturer in 2011, and became an Associate Professor in 2015 and a Professor in
2019. From 2019 to 2022, he was a Professor at the School of Computer Science
at the University of Adelaide, an ARC Future Fellow, and the Director of
Medical Machine Learning at the Australian Institute of Machine Learning. He is
currently a Professor of AI and Machine Learning at the University of Surrey,
UK. His research interests lie in the applied research in medical image analysis
and computer vision to theoretical research in machine learning.
Spencer Thomas is a Senior Research Scientist in Data Science at the National Physical Laboratory (NPL) and a Senior Lecturer at the Department of Computer Science at the University of Surrey. He received an undergraduate master’s degree in physics (M.Phys) in 2010 and completed his Ph.D. in Optimisation and Computational Biology in 2014 from the University of Surrey. His research focuses on machine learning in large-scale high-dimensional systems and multi-modal healthcare data. He is currently leading activities in trustworthy machine learning, curation of large complex data, and healthcare applications in Data Science at NPL.
Christos Mikropoulos is a Consultant Clinical Oncologist
specializing in the treatment of colorectal and urological cancers, including
prostate, bladder, and testicular. He received his M.Sc. from Newcastle
University and his M.D. from the University of London, Institute of Cancer Research
(ICR). He is trained in advanced techniques for radiotherapy including MR
Linac, SABR, and Brachytherapy. Currently, he is a Clinical Oncology Consultant
at the Royal Surrey NHS Foundation Trust where he also treats Haematological
Malignancies with Radiotherapy and Stereotactic Radiotherapy for
Oligometastatic Disease. His research interests include prostate cancer,
bladder cancer, testicular cancer, prostate brachytherapy, gynaecological
cancers, and colorectal cancer.
Philip M Evans is an Emeritus Professor of Medical Radiation Imaging at The Centre
for Vision Speech and Signal Processing (CVSSP), The University of Surrey. He
has a first degree from The University of Aston and a DPhil from The University
of Oxford. He has won grant funding from Cancer Research UK, The Wellcome
Trust, The National Institute for Healthcare Research, The Medical Research
Council, EPSRC, and STFC. Between 2018 and 2022, he took on the role
of CVSSP and NPL (National Physical Laboratory) Professor of Medical Imaging. His
main research interests involve the application of physics and engineering to
medical imaging problems, particularly in radiotherapy.
Stergios Boussios specialized in Internal Medicine in
Komotini, Greece (2007–2009). Subsequently, he trained in Medical Oncology at
the Ioannina University Hospital, Greece (2010–2013). He was awarded the
European School of Oncology (ESO) and Hellenic Society of Medical Oncology
(HeSMO) fellowships for Clinical and Laboratory Research at the Royal Marsden
Hospital, London, UK (2014–2015). He holds a Ph.D from the University of
Ioannina, Greece (2016). He was selected by the European Society of Medical
Oncology (ESMO) Fellowship and Award Committee to be part of the ESMO Leaders
Generation Programme in 2017. Since April 2018, he has served as a Consultant
at the Department of Medical Oncology, Medway NHS Foundation Trust, UK, and is
the research lead in the CUP. He is actively involved in translational research
in cancer and is the principal investigator in phase I–III studies. In October
2020, he received the title of Honorary Senior Lecturer from King’s College
London (School of Cancer and Pharmaceutical Sciences). Since November 2023, he
has been honored with the designation of Visiting Professor at Canterbury
Christ Church University. His research interests include individualization of
patient treatment and targeted therapies in gynecological cancers, CUP,
urological cancers, new drug development, and cancer diagnosed in pregnancy.
